MedPath

ALTALITY, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:1
Completed:0

Trial Phases

2 Phases

Early Phase 1:1
Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Early Phase 1
1 (50.0%)
Phase 1
1 (50.0%)

An English/Spanish Mobile Augmented Reality Pain Assessment App for Hispanic/Latino Pediatric Cancer Patients

Early Phase 1
Active, not recruiting
Conditions
Pain
Pediatric Cancer
First Posted Date
2024-10-10
Last Posted Date
2024-10-26
Lead Sponsor
ALTality, Inc.
Target Recruit Count
16
Registration Number
NCT06635434
Locations
🇺🇸

MD Anderson Cancer Center, Houston, Texas, United States

A Pilot Randomized Controlled Trial for Feasibility of Administering an AR Game to Postoperative Pediatric Cancer Patients

Phase 1
Conditions
Pediatric Cancer
Surgery
First Posted Date
2020-12-19
Last Posted Date
2021-08-16
Lead Sponsor
ALTality, Inc.
Target Recruit Count
20
Registration Number
NCT04674150
Locations
🇺🇸

M.D. Anderson Cancer Center, Houston, Texas, United States

🇺🇸

Texas Children's Hospital, Houston, Texas, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.